Fill and Finish
How we work
Magle Group’s vascular embolic product Embocept® S receives regulatory approval in Argentina
Magle Chemoswed Holding AB announces change of Certified Adviser to Vator Securities
First patients enrolled in a post-market study of Magle Group’s innovative medical device SmartPAN®
Magle Group announces innovation sponsorship with leading life science incubator in Sweden
Magle Group announces post market clinical study for SmartPAN®
Magle Group signs pre-agreement to acquire land in Malmö
EmboCept®S included in the European treatment guidelines
Magle Chemoswed establishes a manufacturing agreement with Oncopeptides
Magle Chemoswed announces confirmation of manufacturing order for delivery in 2022.
Magle Chemoswed Holding (publ) today announced that it has filed a patent application that will be used in the ongoing SmartBONE project in the field of bone tissue engineering.